Physician profile
Beili Dong
NPI 1225269186
$1,693.54
in general payments reported to CMS, 2019-2025
19 companies · $281 in 2025
The $281 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $899 · 2020: $55.28 · 2022: $294 · 2023: $146 · 2024: $18.71 · 2025: $281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $445.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $445.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $340.43 | 2023-2025 | Auvelity |
| Neurocrine Biosciences, INC. | $273.53 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $178.01 | 2022-2024 | Trintellix |
| Sunovion Pharmaceuticals INC. | $154.24 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $121.67 | 2019 | |
| Vertical Pharmaceuticals, LLC | $94.37 | 2019-2025 | Relexxii |
| Lundbeck LLC | $87.95 | 2019 | |
| Vanda Pharmaceuticals INC. | $87.45 | 2019 | |
| Jazz Pharmaceuticals INC. | $72.54 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $60.62 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $50.00 | 2023 | Tagrisso |
| Ironshore Pharmaceuticals INC. | $36.31 | 2019 | |
| Neos Therapeutics, LP | $31.66 | 2019 | |
| Bausch Health US, LLC | $25.18 | 2019-2020 | |
| Tris Pharma INC | $23.69 | 2019-2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adlon Therapeutics L.P. | $16.07 | 2019 | |
| Shire North American Group INC | $14.39 | 2019 | |
| Alkermes, INC. | $13.01 | 2019 | |
| Sage Therapeutics, LLC | $12.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beili Dong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.